The results showed that nano-realgar may be a potential agent for LN treatment, and it down- regulated the expression of p-STAT1, suggesting that nano-realgar may be one of the therapeutic targets of LN (Xu et al., 2019) (Figure 2). Here, STAT1 is linked to lobular neoplasia.